Authors:
ERKISI M
BILKAY BC
SEYREK E
HAZAR B
BURGUT R
Citation: M. Erkisi et al., REFRACTORY BREAST-CANCER - A COMPARISON OF 2 DIFFERENT CHEMOTHERAPY REGIMENS, Journal of chemotherapy, 9(6), 1997, pp. 442-445
Authors:
ERKISI M
ERKURT E
OZBARLAS S
BURGUT R
DORAN F
SEYREK E
Citation: M. Erkisi et al., THE USE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR INCOMBINATION WITH SINGLE OR FRACTIONATED DOSES OF IFOSFAMIDE AND DOXORUBICIN IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA, Journal of chemotherapy, 8(3), 1996, pp. 224-228
Authors:
ERKISI M
ERKURT E
OZBARLAS S
BURGUT R
DORAN F
SEYREK E
Citation: M. Erkisi et al., THE USE OF R-MET HU 6-CSF IN COMBINATION WITH HIGH AND STANDARD DOSESOF IFOSFAMIDE AND DOXORUBICIN IN THE PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA, European journal of cancer, 31A, 1995, pp. 855-855
Authors:
SOYLU L
OZCAN C
CETIK F
PAYDAS S
KIROGLU M
AYDOGAN B
SARGIN O
OZSAHINOGLU C
SEYREK E
Citation: L. Soylu et al., SERUM LEVELS OF TUMOR-NECROSIS-FACTOR IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, American journal of otolaryngology, 15(4), 1994, pp. 281-285